219 related articles for article (PubMed ID: 32944406)
21. Slit-Robo GTPase-Activating Protein 2 as a metastasis suppressor in osteosarcoma.
Marko TA; Shamsan GA; Edwards EN; Hazelton PE; Rathe SK; Cornax I; Overn PR; Varshney J; Diessner BJ; Moriarity BS; O'Sullivan MG; Odde DJ; Largaespada DA
Sci Rep; 2016 Dec; 6():39059. PubMed ID: 27966608
[TBL] [Abstract][Full Text] [Related]
22. Protein kinase, membrane‑associated tyrosine/threonine 1 is associated with the progression of colorectal cancer.
Jeong D; Kim H; Kim D; Ban S; Oh S; Ji S; Kang D; Lee H; Ahn TS; Kim HJ; Bae SB; Lee MS; Kim CJ; Kwon HY; Baek MJ
Oncol Rep; 2018 Jun; 39(6):2829-2836. PubMed ID: 29658598
[TBL] [Abstract][Full Text] [Related]
23. Aven-mediated checkpoint kinase control regulates proliferation and resistance to chemotherapy in conventional osteosarcoma.
Baranski Z; Booij TH; Cleton-Jansen AM; Price LS; van de Water B; Bovée JV; Hogendoorn PC; Danen EH
J Pathol; 2015 Jul; 236(3):348-59. PubMed ID: 25757065
[TBL] [Abstract][Full Text] [Related]
24. PLK2 phosphorylates and inhibits enriched TAp73 in human osteosarcoma cells.
Hu ZB; Liao XH; Xu ZY; Yang X; Dong C; Jin AM; Lu H
Cancer Med; 2016 Jan; 5(1):74-87. PubMed ID: 26625870
[TBL] [Abstract][Full Text] [Related]
25. S1P/S1PR3 axis promotes aerobic glycolysis by YAP/c-MYC/PGAM1 axis in osteosarcoma.
Shen Y; Zhao S; Wang S; Pan X; Zhang Y; Xu J; Jiang Y; Li H; Zhang Q; Gao J; Yang Q; Zhou Y; Jiang S; Yang H; Zhang Z; Zhang R; Li J; Zhou D
EBioMedicine; 2019 Feb; 40():210-223. PubMed ID: 30587459
[TBL] [Abstract][Full Text] [Related]
26. CKM and TERT dual promoters drive CRISPR-dCas9 to specifically inhibit the malignant behavior of osteosarcoma cells.
Hu Y; Zhang H; Guo Z; Zhou J; Zhang W; Gong M; Wu J
Cell Mol Biol Lett; 2023 Jul; 28(1):52. PubMed ID: 37415116
[TBL] [Abstract][Full Text] [Related]
27. Heat shock protein 90B1 plays an oncogenic role and is a target of microRNA-223 in human osteosarcoma.
Li G; Cai M; Fu D; Chen K; Sun M; Cai Z; Cheng B
Cell Physiol Biochem; 2012; 30(6):1481-90. PubMed ID: 23208072
[TBL] [Abstract][Full Text] [Related]
28. Cyclin G-associated kinase is necessary for osteosarcoma cell proliferation and receptor trafficking.
Susa M; Choy E; Liu X; Schwab J; Hornicek FJ; Mankin H; Duan Z
Mol Cancer Ther; 2010 Dec; 9(12):3342-50. PubMed ID: 20881269
[TBL] [Abstract][Full Text] [Related]
29. CRISPR/Cas9-mediated double knockout of SRPK1 and SRPK2 in a nasopharyngeal carcinoma cell line.
Prattapong P; Ngernsombat C; Aimjongjun S; Janvilisri T
Cancer Rep (Hoboken); 2020 Apr; 3(2):e1224. PubMed ID: 32671994
[TBL] [Abstract][Full Text] [Related]
30. The kinase Mirk is a potential therapeutic target in osteosarcoma.
Yang C; Ji D; Weinstein EJ; Choy E; Hornicek FJ; Wood KB; Liu X; Mankin H; Duan Z
Carcinogenesis; 2010 Apr; 31(4):552-8. PubMed ID: 20042639
[TBL] [Abstract][Full Text] [Related]
31. [Development and applications of CRISPR/Cas9 library screening technology in cancer research].
Lei T; Xiao B; He Y; Qu J; Sun Z; Li L
Nan Fang Yi Ke Da Xue Xue Bao; 2019 Nov; 39(11):1381-1386. PubMed ID: 31852637
[TBL] [Abstract][Full Text] [Related]
32. The histone acetyltransferase HBO1 functions as a novel oncogenic gene in osteosarcoma.
Gao YY; Ling ZY; Zhu YR; Shi C; Wang Y; Zhang XY; Zhang ZQ; Jiang Q; Chen MB; Yang S; Cao C
Theranostics; 2021; 11(10):4599-4615. PubMed ID: 33754016
[TBL] [Abstract][Full Text] [Related]
33. Kinome-wide CRISPR-Cas9 knockout screens revealed PLK1 as a therapeutic target for osteosarcoma.
Wang R; Wang D; Bai X; Guo J; Xia S; Cheng Y; Gu Y; Wang Q; Nie J; Chen D; Liu W; Liang J
Cell Death Discov; 2023 Jul; 9(1):231. PubMed ID: 37419907
[TBL] [Abstract][Full Text] [Related]
34. Genome-scale CRISPR-Cas9 knockout and transcriptional activation screening.
Joung J; Konermann S; Gootenberg JS; Abudayyeh OO; Platt RJ; Brigham MD; Sanjana NE; Zhang F
Nat Protoc; 2017 Apr; 12(4):828-863. PubMed ID: 28333914
[TBL] [Abstract][Full Text] [Related]
35. Kinome-wide functional genomics screen reveals a novel mechanism of TNFα-induced nuclear accumulation of the HIF-1α transcription factor in cancer cells.
Schoolmeesters A; Brown DD; Fedorov Y
PLoS One; 2012; 7(2):e31270. PubMed ID: 22355351
[TBL] [Abstract][Full Text] [Related]
36. The tumor suppressor role of PAQR3 in osteosarcoma.
Ma Z; Wang Y; Piao T; Li Z; Zhang H; Liu Z; Liu J
Tumour Biol; 2015 May; 36(5):3319-24. PubMed ID: 25510670
[TBL] [Abstract][Full Text] [Related]
37. Knockdown of YAP1 inhibits the proliferation of osteosarcoma cells in vitro and in vivo.
Yang Z; Zhang M; Xu K; Liu L; Hou WK; Cai YZ; Xu P; Yao JF
Oncol Rep; 2014 Sep; 32(3):1265-72. PubMed ID: 24993351
[TBL] [Abstract][Full Text] [Related]
38. TEAD1 mediates the oncogenic activities of Hippo-YAP1 signaling in osteosarcoma.
Chai J; Xu S; Guo F
Biochem Biophys Res Commun; 2017 Jun; 488(2):297-302. PubMed ID: 28483529
[TBL] [Abstract][Full Text] [Related]
39. Identifying synthetic lethal targets using CRISPR/Cas9 system.
Dhanjal JK; Radhakrishnan N; Sundar D
Methods; 2017 Dec; 131():66-73. PubMed ID: 28710008
[TBL] [Abstract][Full Text] [Related]
40. The identification and characterisation of autophagy inhibitors from the published kinase inhibitor sets.
Zachari M; Rainard JM; Pandarakalam GC; Robinson L; Gillespie J; Rajamanickam M; Hamon V; Morrison A; Ganley IG; McElroy SP
Biochem J; 2020 Feb; 477(4):801-814. PubMed ID: 32011652
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
